Relay Therapeutics, Inc. (RLAY) Tops Q4 EPS by 12c

Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q4 EPS of ($0.45), $0.12 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.

You May Also Be Interested In

• Evercore ISI Reiterates In Line Rating on Texas Roadhouse (TXRH)
• NerdWallet, Inc (NRDS) Misses Q2 EPS by 3c ; Offers Guidance
• JPMorgan Upgrades BGF Retail Co Ltd. (282330:KS) to Overweight